CXCL12 expression is associated with T-bet abundance and longer survival in lung adenocarcinoma
The tissue immune context and clinical significance of CXCL12 in lung adenocarcinoma (LUAD) remain unresolved. We integrated transcriptomic and tissue analyses to characterize CXCL12-associated immune features and survival. TCGA-LUAD analyses included 515 primary tumors and 502 patients with overall surviv...